Literature DB >> 2808787

Age and malignant melanoma: comparison of variables in different age-groups.

J K Rivers1, M C Kelly, A W Kopf, B Welkovich, R S Bart.   

Abstract

Variables were compared in patients with clinical stage I superficial spreading melanoma who had been divided into three age-groups. The study included 736 consecutive patients who were prospectively entered into the data base of the Melanoma Cooperative Group of New York University Medical Center. Compared with the younger patients ( less than 40 years), older patients (greater than or equal to 60 years) had superficial spreading melanomas that were, on average, of greater thickness, level, and diameter. Younger patients were more likely than older patients to show evidence that their melanomas arose from preexisting nevocytic nevi. There was no difference in the 10-year survival between groups when melanomas were matched by thickness. Thus it is as important to perform periodic total cutaneous examinations in the elderly as it is in younger persons, and age alone should not determine management strategies.

Entities:  

Mesh:

Year:  1989        PMID: 2808787     DOI: 10.1016/s0190-9622(89)70243-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Melanoma in people aged 65 and over.

Authors:  C C Harland; R A Marsden; M E Fallowfield
Journal:  BMJ       Date:  1992-04-18

2.  Melanoma in people aged 65 and over in Scotland, 1979-89.

Authors:  P M McHenry; D J Hole; R M MacKie
Journal:  BMJ       Date:  1992-03-21

3.  Ultraviolet radiation-induced skin lesions in laboratory opossums (Monodelphis domestica) exposed from the weanling stage.

Authors:  E S Robinson; G B Hubbard; J L VandeBerg
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Malignant melanoma in the elderly: different regional disease and poorer prognosis.

Authors:  James B Macdonald; Amylou C Dueck; Richard J Gray; Nabil Wasif; David L Swanson; Aleksandar Sekulic; Barbara A Pockaj
Journal:  J Cancer       Date:  2011-11-01       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.